KaloBios dips as Sanofi Pasteur returns infection-fighting drug
Sanofi Pasteur returned the rights to an experimental infection-fighting drug to KaloBios Pharmaceuticals Inc., sending the South San Francisco company's stock to a new 52-week low.
Sun Jul 27, 2014
Detroit Free Press
Vaccine may replace icky cure for intestinal bacteria
It's no secret to anyone who lives or works in the city that Detroit has the highest tax rates in... At least five providers are working with Sanofi Pasteur on its clinical trial.
Thu Jul 24, 2014
[In Depth] Dengue vaccine trial poses public health quandary
The first large efficacy trial of a vaccine for the tropical disease dengue has returned puzzling results.
Tue Jul 22, 2014
Sanofi Pasteur Begins Shipping Seasonal Influenza Vaccine for...
Sanofi Pasteur, the vaccines division of Sanofi, announced today that the first lots of Fluzone for the 2014-2015 influenza season have been released by the U.S. Food and Drug Administration for distribution.
Sun Jul 13, 2014
Malaysian National News Agency
Vaccine Firm Warns India Against Pakistan Polio Threat
The large cases of polio virus in Pakistan pose a threat to its neighbours such as India, the world's leading polio vaccine manufacturers has warned, the Press Trust of India reported.
Thu Jul 10, 2014
Trial: dengue shot offers some protection
The most advanced vaccine for dengue only offers modest protection but could still help millions of people avoid the devastating effects of the disease known as "breakbone fever," according to a large trial.
First Ever Dengue Vaccine Candidate To Show Efficacy Against Dengue...
July 11, 2014 - Sanofi Pasteur, the vaccines division of Sanofi , today announced the publication in The Lancet of the detailed results of its first landmark phase III dengue vaccine efficacy study conducted in five countries in Asia.
Kids to benefit most from new dengue vaccine
Children who have been infected with mosquito-borne dengue fever will most benefit from a candidate vaccine to protect them against a potentially deadly hemorrhagic fever, researchers say.